Heparin-based ELISA reduces background reactivity in virus-like particle-based papillomavirus serology
- 1 January 2005
- journal article
- research article
- Published by Microbiology Society in Journal of General Virology
- Vol. 86 (1) , 65-73
- https://doi.org/10.1099/vir.0.80472-0
Abstract
The interaction between human papillomavirus (HPV) particles and cell surface heparan sulfate requires intact conformation of the HPV particles. Type-specific HPV serology is currently based on virus-like particles (VLPs) with intact conformation. Presence of incorrectly folded VLPs in VLP preparations is recognized as an important cause of cross-reactivity in HPV serology. Heparin-coated microtitre plates were evaluated for capturing conformationally correct VLPs and improving the type specificity of HPV serology. Hybrid VLPs between HPV16 and HPV11, which had been found to have significant reactivity with children's sera and a batch of HPV18 VLPs that had failed the quality control because of significant reactivity with sera from virginal women, were tested in parallel with heparin ELISA, ordinary ELISA and type-specific mAb capture ELISA. Control sera from children that had detectable reactivity with HPV16/11 hybrid VLPs in ordinary ELISA did not react in heparin-based ELISA, but some hybrid VLPs also had background reactivity in capture ELISAs. Control sera from virginal women that had some reactivity with a poor quality HPV18 VLP preparation in ordinary ELISA had no reactivity in heparin or capture ELISA, suggesting that certain VLP preparations expose cross-reactive epitopes that are not exposed on VLPs with heparin-binding ability. As the sensitivity was similar or only marginally affected by the use of heparin plates, use of heparin-coated plates may improve the type specificity of VLP-based ELISAs and reduce interassay variability attributable to variable quality of different VLP batches.Keywords
This publication has 25 references indexed in Scilit:
- Heparan sulfate proteoglycans interact exclusively with conformationally intact HPV L1 assemblies: Basis for a virus‐like particle ELISAJournal of Medical Virology, 2004
- Different Heparan Sulfate Proteoglycans Serve asCellular Receptors for HumanPapillomavirusesJournal of Virology, 2003
- Enhanced Enzyme-Linked Immunosorbent Assay for Detection of Antibodies to Virus-Like Particles of Human PapillomavirusJournal of Clinical Microbiology, 2002
- Gene transfer using human papillomavirus pseudovirions varies according to virus genotype and requires cell surface heparan sulfateFEMS Microbiology Letters, 2001
- Type Specificity and Significance of Different Isotypes of Serum Antibodies to Human Papillomavirus CapsidsThe Journal of Infectious Diseases, 2000
- The serological response to papillomavirusesSeminars in Cancer Biology, 1999
- Infectious human papillomavirus type 18 pseudovirionsJournal of Molecular Biology, 1998
- The disruption of cell cycle checkpoints by papillomavirus oncoproteins contributes to anogenital neoplasiaSeminars in Cancer Biology, 1996
- Comparison of Development of Serum Antibodies to HPV16 and HPV33 and Acquisition of Cervical HPV DNA Among Sexually Experienced and Virginal Young GirlsSexually Transmitted Diseases, 1996
- Association of Serum Immunoglobulin G Antibodies Against Human Papillomavirus Type 16 Capsids With Anal Epidermoid CarcinomaJNCI Journal of the National Cancer Institute, 1995